-
Exagamglogene autotemcel, sold
under the
brand name Casgevy, is a gene
therapy used for the
treatment of
sickle cell
disease and transfusion-dependent...
- of the Year
Award (FOYA)
award in 2022. The company’s lead program,
exagamglogene autotemcel, or exa-cel (formerly CTX001), was
granted regulatory approval...
-
elivaldogene autotemcel Skysona cerebral adrenoleukodystrophy 16 July 2021
exagamglogene autotemcel Casgevy Ex vivo
Vertex Pharmaceuticals sickle cell disease...
-
levels (with no
significant decreases in
liver or
cardiac iron levels).
Exagamglogene autotemcel was
approved for
medical use in the
United Kingdom in November...
- Casgevy, to
treat sickle-cell
anemia and beta thal****emia. Casgevy, or
exagamglogene autotemcel,
directly acts on the
genes of the stem
cells inside the...
-
require further research to
determine their effectiveness. In 2023, both
exagamglogene autotemcel and
lovotibeglogene autotemcel were
approved for the treatment...
- Exo-cell may be a
misspelling of: Exa-cell,
exagamglogene autotemcel Exocell, an
organism in the
video game Cold Fear This
disambiguation page
lists articles...
- INN)
everolimus (USAN) Evex
Evista (Eli
Lilly and Company)
Evoxac exagamglogene autotemcel (INN)
exalamide (INN)
exametazime (INN)
examorelin (INN)...
-
Medications like deferoxamine,
deferiprone and luspatercept. Gene therapy,
exagamglogene autotemcel is
approved for
medical use in the
United Kingdom since November...
-
Betibeglogene autotemcel B06AX03
Voxelotor B06AX04
Mitapivat B06AX05
Exagamglogene autotemcel "ATC (Anatomical
Therapeutic Chemical classification System)...
